Stockreport

Stock Market Today, Jan. 15: ImmunityBio Surges After Anktiva Revenue Jumps 700% [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF The stock jumped after preliminary 2025 results highlighted roughly 700% growth in Anktiva revenue and a quarterly sales beat. Investors are watching ongoing demand tren [Read more]